Modern possibilities of therapy for primary cutaneous T-cell lymphomas: the first results of the use of brentuximab vedotin in the Russian Federation
Background. Primary cutaneous T-cell lymphomas are rare heterogeneous group of lymphoproliferative diseases characterized by primarily involving skin and subcutaneous adipose tissue. Half of these cases are mycosis fungoides (MF), for about 25% are cutaneous CD30+ lymphoproliferative diseases (CD30+...
Guardado en:
Autores principales: | Liliya G. Gorenkova, Irena E. Belousova, Sergei K. Kravchenko, Alla M. Kovrigina, Yulia V. Sidorova, Nataliya V. Ryzhikova, Elena E. Lepik, Tatiana V. Shneyder |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
IP Habib O.N.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/291b30b07346424bbc06b3d2d3266eb0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The Evolving Role of Brentuximab Vedotin in Classical Hodgkin Lymphoma
por: Lai C, et al.
Publicado: (2019) -
New opportunities of systemic therapy of CD30-positive primary cutaneous T-cell lymphomas
por: Irina V. Poddubnaya, et al.
Publicado: (2020) -
Modern approaches in the first line treatment of CD30-positive peripheral T-cell lymphomas
por: Irina V. Poddubnaya, et al.
Publicado: (2021) -
Hodgkin lymphoma. ASCO, EHA and ASH 2020 news
por: Elena A. Demina
Publicado: (2021) -
Promising Immunotherapeutic Modalities for B-Cell Lymphoproliferative Disorders
por: Jana Mihályová, et al.
Publicado: (2021)